Figure 12.
(A) Optical fibre insertion monitored by T 2 weighted MRI. (B) Survival curves obtained after illumination for control and PS@AGuIX NPs-treated groups.(C) Survival curves obtained after illumination for control, non-responder and responder groups. (D) Relative growth of the tumour diameters for the different animals and determination of non-responder and responder groups. (E) Relative levels of metabolites measured by MRS 1 day after treatment. (F) Relative levels of metabolites measured by MRS two days after treatment. (G) Relative levels of metabolites measured by MRS 3 days after treatment. Adapted from.76 MRS, magnetic resonance spectroscopy; NPs, nanoparticles.